Silverarc Capital Management »

Rocket Pharmaceuticals shares owned by Silverarc Capital Management

Quarter-by-quarter ownership of Rocket Pharmaceuticals (RCKTW) shares owned by Silverarc Capital Management from 13F filings

Historical chart of Silverarc Capital Management investment in Rocket Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Rocket Pharmaceuticals held by Silverarc Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rocket Pharmaceuticals by Silverarc Capital Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $18k 105k 0.17
2023-06-30 $20k 105k 0.19
2023-03-31 $12k 105k 0.11

More positions owned by Silverarc Capital Management

ImmunoGen Long Option Calls Call Option
SPRD S&P Biotech ETF Long Option Calls Call Option (XBI)
Akero Therapeutics Long Option Calls Call Option (AKRO)
Mirati Therapeutics Long Option Calls Call Option
Morphic Holding Equities (MORF)
Merus NV Equities (MRUS)
CymaBay Therapeutics Long Option Calls Call Option
Soleno Therapeutics Equities (SLNO)
Intra-Cellular Therapies Equities (ITCI)
Poseida Therapeutics Equities (PSTX)
Krystal Biotech Equities (KRYS)
Mersana Therapeutics Long Option Calls Call Option (MRSN)
KalVista Pharmaceuticals Long Option Calls Call Option (KALV)
Biogen Idec Equities (BIIB)
Urogen Pharma Equities (URGN)

View all positions for Silverarc Capital Management

Top funds holding Rocket Pharmaceuticals

Walleye Trading Advisors
Fort Baker Capital Management
Citadel Advisors
Jpmorgan Chase & Co
LMR Partners
Walleye Trading
Cowen And Company
Skaana Management
Ancora Advisors

View all funds holding Rocket Pharmaceuticals